These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4053130)

  • 21. Renal haemodynamics in hypertension: effects of antihypertensive drugs.
    Dupont AG
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S42-5. PubMed ID: 8487249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 23. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
    Fujihara CK; Malheiros DM; Zatz R
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of renal hemodynamics.
    Maher JF
    Nephron; 1981; 27(4-5):215-21. PubMed ID: 7266710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.
    De Rosa ML; Cardace P; Rossi M; Baiano A; de Cristofaro A
    J Hum Hypertens; 2002 Feb; 16(2):133-40. PubMed ID: 11850771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antihypertensive therapy on the hemodynamics of hypertension: clinical implications.
    Lund-Johansen P
    Clin Ther; 1986; 8(4):382-97. PubMed ID: 3524841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension].
    Werning C; Stiel D; Hammann K; Schweikert HU; Fischer N; Siegenthaler W
    Fortschr Med; 1972 Jul; 90(20):785-7. PubMed ID: 5074231
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal consequences of antihypertensive therapy.
    Eknoyan G; Suki WN
    Semin Nephrol; 1991 Mar; 11(2):129-37. PubMed ID: 1674622
    [No Abstract]   [Full Text] [Related]  

  • 29. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade.
    Wysocki M; Andersson OK; Persson B; Bagge U
    Angiology; 1998 Jan; 49(1):41-8. PubMed ID: 9456163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive drug management of hypertension.
    Oparil S; Winternitz S
    Cardiovasc Clin; 1984; 14(3):73-91. PubMed ID: 6144392
    [No Abstract]   [Full Text] [Related]  

  • 33. [Etiology and treatment of diuretic resistance].
    Risler T; Braun N; Erley C
    Wien Med Wochenschr; 1996; 146(16):447-50. PubMed ID: 9036681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive measurement of intrarenal blood flow distribution: kinetic model of renal 123I-hippuran handling.
    Janssen WM; Beekhuis H; de Bruin R; de Jong PE; de Zeeuw D
    Am J Physiol; 1995 Oct; 269(4 Pt 2):F571-80. PubMed ID: 7485544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
    Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal effects of nitrendipine.
    Ruilope LM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacologic principles of the therapy of hypertension].
    Kiesewetter R; Linss G
    Z Arztl Fortbild (Jena); 1984; 78(24):1039-46. PubMed ID: 6396976
    [No Abstract]   [Full Text] [Related]  

  • 38. Participation of renal and circulating endothelin in salt-sensitive essential hypertension.
    Elijovich F; Laffer CL
    J Hum Hypertens; 2002 Jul; 16(7):459-67. PubMed ID: 12080429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kidney function during therapy of hypertension].
    Kiesewetter E; Wohlzogen FX; Mostbeck A
    Int J Clin Pharmacol; 1973 Jul; 7(4):316-22. PubMed ID: 4199251
    [No Abstract]   [Full Text] [Related]  

  • 40. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.